Efficacy Study Comparing 0.9 g and 1.25 g EstroGel?? 0.03% Doses With Placebo in the Treatment of Vasomotor Symptoms and Vulvar and Vaginal Atrophy Associated With Menopause.
Phase of Trial: Phase IV
Latest Information Update: 27 Apr 2010
At a glance
- Drugs Estradiol (Primary)
- Indications Menopausal syndrome
- Focus Therapeutic Use
- Sponsors Abbott Laboratories; ASCEND Therapeutics
- 12 Oct 2006 Status change
- 27 Nov 2005 New trial record.